Creating new treatments for asthma
Development of Novel Therapeutics for Asthma
This study is looking for new and better treatments for asthma that are safer and more effective, using advanced computer models and experiments to understand how certain immune cells and metabolism affect the condition.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Biotherapeutics, INC. NIH-funded |
| Lab location | 1 site (Blacksburg, United States) |
| Project ID | NIH-11008453 on NIH RePORTER |
What this research studies
This research focuses on developing innovative therapeutics for asthma by utilizing advanced computational modeling and experimental techniques. The goal is to create precision medicine solutions that address the limitations of current asthma treatments, which often have inadequate efficacy and significant side effects. By exploring the role of regulatory T cells and metabolic factors in asthma, the research aims to identify safer and more effective options for patients suffering from this chronic condition.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with asthma, particularly those who have not responded well to existing therapies.
Not a fit: Patients with mild asthma who are well-controlled on current therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer and more effective asthma treatments, improving the quality of life for patients.
How similar studies have performed: While there have been challenges in developing new asthma therapies, the innovative approach of targeting regulatory T cells and metabolic factors represents a novel direction that has not been extensively tested.
Where this research is happening
Blacksburg, United States
- Biotherapeutics, INC. — Blacksburg, United States (Active)
Researchers
- Principal investigator: Bassaganya-Riera, Josep — Biotherapeutics, INC.
- Study coordinator: Bassaganya-Riera, Josep
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.